skip to content

Wellcome-MRC Cambridge Stem Cell Institute

 
Read more at: CSCI welcomes new cohort of postgraduate students

CSCI welcomes new cohort of postgraduate students

8 December 2022

A total of 26 new Postgraduate students started at CSCI in October 2022, under the supervision of 11 different PIs within the Institute. These students are on a variety of PhD and Masters programmes, and are based in the following labs: Wellcome MRes + PhD Programme (currently doing rotations): 6 students CCMR MRes + PhD...


Read more at: Off-patent liver disease drug could prevent COVID-19 infection

Off-patent liver disease drug could prevent COVID-19 infection

5 December 2022

Cambridge scientists from the Sampaziotis lab show that a widely used drug to treat liver disease can prevent COVID-19 infection or reduce disease severity Cambridge Stem Cell Institute scientists have identified an off-patent drug that can be repurposed to prevent COVID-19 – and may be capable of protecting against future...


Read more at: Stem Cells IRC workshop winners announced

Stem Cells IRC workshop winners announced

18 November 2022

Winners from the Collaboration Creation Days workshop have been awarded this week for their proposals presented at the end of the event. In September, the Wellcome-MRC Cambridge Stem Cell Institute Interdisciplinary Research Centre , together with Sensor CDT , Cambridge Centre for Physical Biology , and the Department of...


Read more at: CSCI scientists take part in first ever clinical trial of lab-grown red blood cells transfused into another person
Removing a small cell sample during clinical trials

CSCI scientists take part in first ever clinical trial of lab-grown red blood cells transfused into another person

7 November 2022

Cambridge researchers are taking part in the world’s first clinical trial of red blood cells that have been grown in a laboratory for transfusion into another person. The manufactured blood cells were grown from stem cells from donors. The red cells were then transfused into volunteers in the RESTORE randomised controlled...


Read more at: Clinical trial for new stem cell-based treatment for Parkinson’s disease to move forward
Elderly hands

Clinical trial for new stem cell-based treatment for Parkinson’s disease to move forward

20 October 2022

Clinical trial for new stem cell-based Parkinson’s disease treatment to move forward Cambridge researchers will play a key role in clinical trials of a new treatment that involves transplanting healthy nerve cells into the brains of patients with Parkinson’s disease. The Swedish Medical Products Agency has granted approval...


Read more at: Zika Virus and Brain Stem Cells in the Developing Brain and Cancer

Zika Virus and Brain Stem Cells in the Developing Brain and Cancer

20 September 2022

University of Cambridge scientists this week demonstrate dramatic differences in the ability of Zika Virus to attack parallel stem cell populations in the developing brain and in malignant brain tumours. The mechanisms uncovered could be important for preventing birth defects and for treating brain tumours in the future...


Read more at: CSCI Welcomes Two New Principal Investigators
CSCI welcomes new PIs

CSCI Welcomes Two New Principal Investigators

20 September 2022

This month, CSCI welcomes two new scientists to join the group of 29 PIs conducting stem cell research in Cambridge. Dr Maria Duque-Correa started her own research group at the Cambridge Institute of Therapeutic Immunology and Infectious Disease at the University of Cambridge in January 2022, and will continue her research...


Read more at: Patient Research & Science Day at CSCI
Matt Zilbauer and a young person at the microscope

Patient Research & Science Day at CSCI

2 September 2022

Last week, the Cambridge Stem Cell Institute (CSCI) welcomed paediatric patients and their families to the Jeffrey Cheah Biomedical Centre for a visit, where they made Play-Doh cells in petri dishes, practiced pipetting samples, and took a tour of the labs with the Milner Therapeutics Institute. Patients of Dr Matthias...


Read more at: CSCI scientists finalise induction into Royal Society
David Rowitch & Ben Simons sign the Charter Book

CSCI scientists finalise induction into Royal Society

25 July 2022

Last month at the Royal Society in London, CSCI scientists Professor David Rowitch and Professor Benjamin Simons were invited to sign the charter of Royal Fellowship, finalising their induction into the Royal Society. While they were initially elected as Fellows in May 2021 , the official ceremony was delayed by COVID-19...


Read more at: Scientists discover genes that affect the risk of developing pre-leukaemia
Test tubes

Scientists discover genes that affect the risk of developing pre-leukaemia

14 July 2022

The discovery of 14 inherited genetic changes which significantly increase the risk of a person developing a symptomless blood disorder associated with the onset of some types of cancer and heart disease is published today in Nature Genetics . The finding, made in one of the largest studies of its kind through genetic data...